IL6 and head and neck squamous cell carcinoma: Thus, in both cetuximab-resistant and cisplatin-resistant HNSCC cells, an increase in IL-6 secretion in conjunction with the emergence of drug resistant cells does not necessarily demonstrate that IL-6 is required for maintenance of drug resistance.